Retrospective study of miscellaneous small Visceral Artery Aneurysms: Results of a single centre-6-year surveillance.

Tools

Otify, Eman, Benaragama, K. S., Nunney, I., Elbasty, A., Wych, J., Armon, M.P., Boyle, J. R. and Stather, P. W. (2026) Retrospective study of miscellaneous small Visceral Artery Aneurysms: Results of a single centre-6-year surveillance. Annals of Vascular Surgery, 133. pp. 456-461. ISSN 0890-5096

[thumbnail of 1-s2.0-S0890509626005777-main]
Preview
 PDF (1-s2.0-S0890509626005777-main)
Available under License Creative Commons Attribution.
Download (2MB) | Preview

Abstract

Background Visceral artery aneurysms (VAAs) are rare with a reported incidence of 0.1 to 2%. However, VAAs are clinically important and can present as life-threatening ruptures that require emergency treatment. The aim of this study was to review our experience with managing VAAs. Methods Retrospective analysis of a prospectively collected database was performed for 88 patients diagnosed with visceral artery aneurysm (VAA) over a 15-year period (2006–2021). Aneurysm size was compared over time using the repeated measures mixed effects model. Results There were 108 VAAs identified in 88 patients, with a mean age of 74.7 years, SD 12.6 (age at presentation or first scan). Of these, 47 (43.5%) were splenic artery aneurysms with a median initial size of 15 mm, 36 (33.4%) were mesenteric artery aneurysms with a median initial size of 14.5 mm, and 25 (23.1%) were renal artery aneurysms with a median initial size of 11 mm. The overall initial median size of the VAA was 15 mm. There is no statistically significant correlation between aneurysm growth rate and any medications or comorbidities. In 88 patients, small VAAs (≤25 mm) were monitored with surveillance imaging with mean surveillance time of 72.7 months and median time of 65 months. Conclusion This study confirms that VAAs <25 mm do not show significant expansion. The important message is that none of the 88 patients’ VAAs increased in size to require treatment. Our study suggests that it may be safe to extend the surveillance interval for small VAAs to 5 years.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 20 Aug 2026 15:29
Last Modified: 10 Sep 2026 11:15
URI: https://ueaeprints.uea.ac.uk/id/eprint/104282
DOI: 10.1016/j.avsg.2026.07.061

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item